323
This month’s two case studies focus on two companies that require imagination and opportunity. One is DAVIDsTEA (DTEA) and they are not at all involved in the cannabis industry.
However, LPs have reportedly knocked on their door and their own financial environment could make them consider this industry and beverages in particular. Their recent board appointment may also suggest they are looking at this industry.
The other company is an American company called MannKind Corporation (MNKD). MNKD has potentially disruptive delivery technology in the treatment of diabetes with an increasing body of clinical data to back it up. MNKD indeed has entered this space and you know from past content that cannabis is a power anti-inflammatory and that chronic inflammation is deemed the “unifying theory of disease”. Our USA edition this month has an article on diabetes and cannabis.
Both companies also have Options one can buy and an introduction to an Options strategy appears as an article in this edition.
Our content can be standalone but also builds on itself. But do remember, our content is always for discussion purposes only and is never intended as financial, investment, or health advice of any kind.
301